Form 4: FactSet Executive Granted Stock Options

Sentiment:

Insider Transaction Report


FactSet Research Systems Inc. executive Gregory T. Moskoff was granted 2,157 employee stock options with an exercise price of $264.57.

Summary

  • Gregory T. Moskoff, MD, Controller, and CAO of FactSet Research Systems Inc. (FDS), acquired 2,157 employee stock options.
  • The options have an exercise price of $264.57 per share.
  • The grant date for these options was November 3, 2025.
  • The options will vest 25% annually on the anniversary date of the grant and will be fully vested after four years.
  • The expiration date for these options is November 3, 2035.

Sentiment

Score: 6

Explanation: Slightly positive, as it represents a routine executive compensation event that aligns management incentives with shareholder interests, without indicating any adverse developments.

Positives

  • The grant of stock options aligns the interests of a key executive (Gregory T. Moskoff) with those of the shareholders, incentivizing long-term company performance.
  • This is a standard component of executive compensation, indicating ongoing commitment to retaining and motivating leadership.

Future Outlook

The options are subject to a four-year vesting schedule, with 25% vesting annually, indicating a long-term incentive structure for the executive.

Industry Context

The grant of employee stock options is a common practice in the financial information and technology industry, used by companies like FactSet to attract, retain, and motivate key executives by linking their compensation to the company's stock performance.

Comparison to Industry Standards

  • The use of stock options with a multi-year vesting schedule is a standard component of executive compensation packages across the technology and financial services sectors, comparable to practices at companies like S&P Global (SPGI), MSCI (MSCI), and Bloomberg.
  • The specific number of options and exercise price are tailored to the executive's role and the company's compensation philosophy, generally reflecting market rates for similar positions in the industry.

Stakeholder Impact

  • Shareholders: The grant of options aims to align executive performance with shareholder value creation, potentially leading to better long-term company performance.
  • Employees: This reflects the company's compensation strategy for its leadership, which can influence overall employee morale and retention strategies.

Next Steps

  • The options will vest annually over the next four years, with the first vesting occurring on November 3, 2026.
  • The executive may choose to exercise the vested options at any point before their expiration date of November 3, 2035, subject to company policy and blackout periods.

Key Dates

DateDescription
11/03/2025Date of option grant and earliest transaction date.
11/03/2026First 25% of options vest (one year after grant).
11/03/2027Second 25% of options vest (two years after grant).
11/03/2028Third 25% of options vest (three years after grant).
11/03/2029Final 25% of options vest, making them fully vested (four years after grant).
11/03/2035Expiration date of the employee stock options.
11/05/2025Signature date of the reporting person's attorney-in-fact.

Keywords

FactSet, FDS, stock options, executive compensation, insider transaction, Form 4, equity grant

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.